122 research outputs found

    ์ƒ๋Œ€์  ๊ทผ์œก๋Ÿ‰๊ณผ ๋Œ€์‚ฌ์ฆํ›„๊ตฐ ๋ฐ ๊ตฌ์„ฑ ์š”์†Œ๋“ค ๊ฐ„์˜ ์—ฐ๊ด€์„ฑ ๋ถ„์„

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋ณด๊ฑด๋Œ€ํ•™์› : ๋ณด๊ฑดํ•™๊ณผ(๋ณด๊ฑดํ•™์ „๊ณต), 2013. 2. ์„ฑ์ฃผํ—Œ.์—ฐ๊ตฌ๋ฐฐ๊ฒฝ: ์—ฐ๋ น์ด ์ฆ๊ฐ€ํ•จ์— ๋”ฐ๋ผ ๊ทผ์œก๋Ÿ‰์ด ๊ฐ์†Œํ•˜๋Š” ๊ทผ์œก๊ฐ์†Œ์ฆ (sarcopenia)์€ ํŠนํžˆ ๋…ธ์ธ์—์„œ ์ธ์Š๋ฆฐ ์ €ํ•ญ์„ฑ, ๋‹น๋‡จ, ๋Œ€์‚ฌ์ฆํ›„๊ตฐ๊ณผ ๊ฐ™์€ ์‹ฌํ˜ˆ๊ด€๊ณ„ ์งˆํ™˜์˜ ์œ„ํ—˜์ธ์ž์™€ ๊ด€๋ จ์ด ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ์•Œ๋ ค์ ธ ์žˆ๋‹ค. ๋ฏธ๊ตญ์˜ ์„ฑ์ธ์„ ๋Œ€์ƒ์œผ๋กœ ์‹œํ–‰ํ•œ ํ•œ ์—ฐ๊ตฌ์—์„œ๋Š” ๊ทผ์œก๊ฐ์†Œ์ฆ ๋ฒ”์ฃผ๊นŒ์ง€ ํฌํ•จ๋˜์ง€ ์•Š๋”๋ผ๋„, ๋‚ฎ์€ ์ƒ๋Œ€์  ๊ทผ์œก๋Ÿ‰ ๋˜ํ•œ ์ธ์Š๋ฆฐ ์ €ํ•ญ์„ฑ ๋ฐ ๋‹น๋‡จ์ „๋‹จ๊ณ„ (prediabetes)์™€ ์—ฐ๊ด€์„ฑ์ด ์žˆ์Œ์„ ๋ณด๊ณ ํ•œ ๋ฐ” ์žˆ๋‹ค. ๋ชฉ์ : ์ด๋ฒˆ ์—ฐ๊ตฌ๋Š” 19์„ธ ์ด์ƒ์˜ ํ•œ๊ตญ์ธ์„ ๋Œ€์ƒ์œผ๋กœ ์ƒ๋Œ€์  ๊ทผ์œก๋Ÿ‰ (appendicular skeletal muscle mass / weight (%))๊ณผ ๋Œ€์‚ฌ์ฆํ›„๊ตฐ ๋ฐ ๊ทธ ๊ตฌ์„ฑ ์š”์†Œ์ธ ์ˆ˜์ถ•๊ธฐ ํ˜ˆ์••, ์ด์™„๊ธฐ ํ˜ˆ์••, ๊ณต๋ณตํ˜ˆ๋‹น, ์ค‘์„ฑ์ง€๋ฐฉ, ๊ณ ๋ฐ€๋„์ง€๋‹จ๋ฐฑ ์ฝœ๋ ˆ์Šคํ…Œ๋กค ๋ฐ ์ธ์Š๋ฆฐ ์ €ํ•ญ์„ฑ ์ง€ํ‘œ์™€ ๊ฐ™์€ ์‹ฌํ˜ˆ๊ด€๊ณ„ ์งˆํ™˜ ์œ„ํ—˜์ธ์ž๋“ค ์‚ฌ์ด์˜ ์—ฐ๊ด€์„ฑ์„ ์•Œ์•„๋ณด๊ณ ์ž ํ•˜์˜€๋‹ค. ๋ฐฉ๋ฒ•: 2008 ~ 2010๋…„์— ์‹œํ–‰๋œ ์ œ4๊ธฐ ~ ์ œ5๊ธฐ 1์ฐจ ๊ตญ๋ฏผ๊ฑด๊ฐ•์˜์–‘์กฐ์‚ฌ์— ์ฐธ์—ฌํ–ˆ๋˜ 12,444๋ช…์˜ ์ž๋ฃŒ๋ฅผ ์ด์šฉํ•˜์—ฌ ๋‹จ๋ฉด ์—ฐ๊ตฌ๋ฅผ ์‹œํ–‰ํ•˜์˜€๋‹ค. ๋ณตํ•ฉํ‘œ๋ณธ ์ž๋ฃŒ์— ๋Œ€ํ•œ ๋‹ค์ค‘๋กœ์ง€์Šคํ‹ฑ ํšŒ๊ท€๋ถ„์„์„ ์ด์šฉํ•˜์—ฌ ์ƒ๋Œ€์  ๊ทผ์œก๋Ÿ‰๊ณผ ๋Œ€์‚ฌ์ฆํ›„๊ตฐ ๋ฐ ๊ทธ ๊ตฌ์„ฑ ์š”์†Œ๋“ค(ํ˜ˆ์•• ์ƒ์Šน, ๊ณต๋ณตํ˜ˆ๋‹น์žฅ์• , ๊ณ ์ค‘์„ฑ์ง€๋ฐฉํ˜ˆ์ฆ, ๋‚ฎ์€ ๊ณ ๋ฐ€๋„์ง€๋‹จ๋ฐฑ ์ฝœ๋ ˆ์Šคํ…Œ๋กค ๋ฐ ๋ณต๋ถ€๋น„๋งŒ)๊ณผ์˜ ์—ฐ๊ด€์„ฑ์„ ๋ถ„์„ํ•˜์˜€๋‹ค. ๋˜ํ•œ, ๋ณตํ•ฉํ‘œ๋ณธ ์ž๋ฃŒ์— ๋Œ€ํ•œ ๋‹ค์ค‘์„ ํ˜•ํšŒ๊ท€๋ถ„์„์„ ์ด์šฉํ•˜์—ฌ ๊ต๋ž€๋ณ€์ˆ˜๋ฅผ ํ†ต์ œํ–ˆ์„ ๋•Œ ์ƒ๋Œ€์  ๊ทผ์œก๋Ÿ‰๊ณผ ๋Œ€์‚ฌ์ฆํ›„๊ตฐ์˜ ์š”์†Œ๋“ค(ํ˜ˆ์••, ๊ณต๋ณตํ˜ˆ๋‹น, ์ค‘์„ฑ์ง€๋ฐฉ, ๊ณ ๋ฐ€๋„์ง€๋‹จ๋ฐฑ ์ฝœ๋ ˆ์Šคํ…Œ๋กค) ๋ฐ ์ธ์Š๋ฆฐ ์ €ํ•ญ์„ฑ ์ง€ํ‘œ ์‚ฌ์ด์˜ ์—ฐ๊ด€์„ฑ์„ ์กฐ์‚ฌํ•˜์˜€๋‹ค. ๋ถ„์„์€ ๋‚จ๋…€ ๊ตฐ์œผ๋กœ ์ธตํ™”ํ•˜์—ฌ ์‹œํ–‰ํ•˜์˜€์œผ๋ฉฐ, ๋‚จ์„ฑ์€ 60์„ธ๋ฅผ ๊ธฐ์ค€์œผ๋กœ, ์—ฌ์„ฑ์€ ํ๊ฒฝ ์ „ํ›„๋ฅผ ๊ธฐ์ค€์œผ๋กœ ๋‚˜๋ˆˆ ๊ทธ๋ฃน์—์„œ๋„ ์ถ”๊ฐ€์ ์œผ๋กœ ๋ถ„์„์„ ์‹œํ–‰ํ•˜์˜€๋‹ค. ๊ฒฐ๊ณผ: ๊ต๋ž€๋ณ€์ˆ˜์˜ ์˜ํ–ฅ์„ ๋ณด์ •ํ•œ ๋’ค, ์ „์ฒด ๋‚จ์„ฑ์—์„œ ์ƒ๋Œ€์  ๊ทผ์œก๋Ÿ‰์ด ์ฒซ ๋ฒˆ์งธ 5๋ถ„์œ„ ๊ตฌ๊ฐ„์— ์†ํ•˜๋Š” ๋Œ€์ƒ์ž์™€ ๋น„๊ตํ•  ๋•Œ, ๋‹ค์„ฏ ๋ฒˆ์งธ 5๋ถ„์œ„ ๊ตฌ๊ฐ„์— ์†ํ•˜๋Š” ์‚ฌ๋žŒ์€ ๋Œ€์‚ฌ์ฆํ›„๊ตฐ์ด ์žˆ์„ ์˜ค์ฆˆ๊ฐ€ 0.166๋ฐฐ(95% ์‹ ๋ขฐ๊ตฌ๊ฐ„ 0.088-0.272)๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค. 60์„ธ ๋ฏธ๋งŒ ๋‚จ์„ฑ์—์„œ๋Š” 0.184๋ฐฐ(95% ์‹ ๋ขฐ๊ตฌ๊ฐ„ 0.117-0.289), 60์„ธ ์ด์ƒ์—์„œ๋Š” 0.132๋ฐฐ(95% ์‹ ๋ขฐ๊ตฌ๊ฐ„ 0.073-0.289)๋กœ ๋ชจ๋‘ ์œ ์˜ํ•œ ์Œ์˜ ์—ฐ๊ด€์„ฑ์„ ๋ณด์˜€๋‹ค. ๋Œ€์‚ฌ์ฆํ›„๊ตฐ์˜ ๊ตฌ์„ฑ ์š”์†Œ์ธ ๊ณต๋ณตํ˜ˆ๋‹น์žฅ์• , ํ˜ˆ์•• ์ƒ์Šน, ๊ณ ์ค‘์„ฑ์ง€๋ฐฉํ˜ˆ์ฆ, ๋‚ฎ์€ ๊ณ ๋ฐ€๋„์ง€๋‹จ๋ฐฑ ์ฝœ๋ ˆ์Šคํ…Œ๋กค ๋ฐ ๋ณต๋ถ€๋น„๋งŒ ๋˜ํ•œ ์ƒ๋Œ€์  ๊ทผ์œก๋Ÿ‰์ด ๋‚ฎ์„์ˆ˜๋ก ๊ทธ ์œ„ํ—˜๋„๊ฐ€ ์ฆ๊ฐ€ํ•˜์˜€์œผ๋ฉฐ 60์„ธ ๋ฏธ๋งŒ๊ณผ 60์„ธ ์ด์ƒ์˜ ๋‚จ์ž ๊ทธ๋ฃน์—์„œ ๋ชจ๋‘ ์œ ์˜ํ•˜๊ฒŒ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ์—ฌ์„ฑ์˜ ๊ฒฝ์šฐ, ํ๊ฒฝ ํ›„ ์—ฌ์„ฑ์—์„œ๋Š” ์ƒ๋Œ€์  ๊ทผ์œก๋Ÿ‰์ด ์ฒซ ๋ฒˆ์งธ 5๋ถ„์œ„ ๊ตฌ๊ฐ„์— ์†ํ•˜๋Š” ๋Œ€์ƒ์ž์™€ ๋น„๊ตํ•  ๋•Œ, ๋‹ค์„ฏ ๋ฒˆ์งธ 5๋ถ„์œ„ ๊ตฌ๊ฐ„์— ์†ํ•˜๋Š” ์‚ฌ๋žŒ์€ ๋Œ€์‚ฌ์ฆํ›„๊ตฐ์ด ์žˆ์„ ์˜ค์ฆˆ๊ฐ€ 0.423๋ฐฐ(95% ์‹ ๋ขฐ๊ตฌ๊ฐ„ 0.297-0.602)๋กœ ์œ ์˜ํ•˜๊ฒŒ ๋‚ฎ์•˜์œผ๋ฉฐ, ์ƒ๋Œ€์  ๊ทผ์œก๋Ÿ‰์ด ๋†’์„์ˆ˜๋ก ๋‚ฎ์€ ๊ณ ๋ฐ€๋„์ง€๋‹จ๋ฐฑ ์ฝœ๋ ˆ์Šคํ…Œ๋กค์„ ์ œ์™ธํ•œ ๊ณต๋ณตํ˜ˆ๋‹น์žฅ์• , ํ˜ˆ์••์ƒ์Šน, ๊ณ ์ค‘์„ฑ์ง€๋ฐฉํ˜ˆ์ฆ, ๋ณต๋ถ€๋น„๋งŒ์˜ ์˜ค์ฆˆ๊ฐ€ ์œ ์˜ํ•˜๊ฒŒ ๊ฐ์†Œํ•˜์˜€๋‹ค. ํ๊ฒฝ ์ „ ์—ฌ์„ฑ์—์„œ๋Š” ์ƒ๋Œ€์  ๊ทผ์œก๋Ÿ‰๊ณผ ๋Œ€์‚ฌ์ฆํ›„๊ตฐ์˜ ์—ฐ๊ด€์„ฑ์ด ์œ ์˜ํ•˜์ง€ ์•Š์•˜๋‹ค. ๊ฒฐ๋ก : ๋‚จ์„ฑ ๋ฐ ํ๊ฒฝ ํ›„ ์—ฌ์„ฑ์—์„œ๋Š” ์ƒ๋Œ€์  ๊ทผ์œก๋Ÿ‰์ด ๋‚ฎ์„์ˆ˜๋ก ๋Œ€์‚ฌ์ฆํ›„๊ตฐ์˜ ์œ„ํ—˜๋„๊ฐ€ ๋†’์•˜์œผ๋ฉฐ ๊ณ ๋ฐ€๋„์ง€๋‹จ๋ฐฑ ์ฝœ๋ ˆ์Šคํ…Œ๋กค์„ ์ œ์™ธํ•œ ๊ฐ๊ฐ์˜ ๊ตฌ์„ฑ ์š”์†Œ๋“ค๊ณผ๋„ ์Œ์˜ ์—ฐ๊ด€์„ฑ์„ ๋ณด์˜€๋‹ค. ์ธ๊ณผ์„ฑ์— ๋Œ€ํ•œ ๋ช…ํ™•ํ•œ ๊ทผ๊ฑฐ๋Š” ์•„์ง ์•Œ๋ ค์ง€์ง€ ์•Š์•˜์œผ๋ฏ€๋กœ ํ–ฅํ›„ ์ถ”๊ฐ€์ ์ธ ๊ฒฝ์‹œ์  ์—ฐ๊ตฌ๊ฐ€ ํ•„์š”ํ•  ๊ฒƒ์œผ๋กœ ๋ณด์ธ๋‹ค.๊ตญ๋ฌธ ์ดˆ๋ก i I. ์„œ๋ก  1 II. ์—ฐ๊ตฌ ๋ฐฉ๋ฒ• 4 1. ์—ฐ๊ตฌ ๋Œ€์ƒ์ž 4 2. ๋Œ€์‚ฌ์ฆํ›„๊ตฐ์˜ ์ง„๋‹จ ๊ธฐ์ค€ 5 3. ๊ทผ์œก๋Ÿ‰์˜ ์ธก์ • ๋ฐ ํ‰๊ฐ€ 5 4. ๋ณ€์ˆ˜๋“ค์˜ ์ธก์ • 6 5. ํ†ต๊ณ„ ๋ถ„์„ 7 III. ์—ฐ๊ตฌ ๊ฒฐ๊ณผ 8 1. ์—ฐ๊ตฌ ๋Œ€์ƒ์ž์˜ ์ผ๋ฐ˜์  ํŠน์„ฑ 8 2.์ƒ๋Œ€์  ๊ทผ์œก๋Ÿ‰๊ณผ ๋Œ€์‚ฌ์ฆํ›„๊ตฐ ๋ฐ ๊ตฌ์„ฑ ์š”์†Œ๋“ค(๊ณต๋ณตํ˜ˆ๋‹น์žฅ์• , ํ˜ˆ์•• ์ƒ์Šน, ๊ณ ์ค‘์„ฑ์ง€๋ฐฉํ˜ˆ์ฆ, ๋‚ฎ์€ ๊ณ ๋ฐ€๋„์ง€๋‹จ๋ฐฑ ์ฝœ๋ ˆ์Šคํ…Œ๋กค, ๋ณต๋ถ€๋น„๋งŒ)๊ณผ์˜ ์—ฐ๊ด€์„ฑ ๋ถ„์„ 9 3.์ƒ๋Œ€์  ๊ทผ์œก๋Ÿ‰๊ณผ ๋Œ€์‚ฌ์ฆํ›„๊ตฐ ๊ตฌ์„ฑ ์š”์†Œ ๋ฐ ์ธ์Š๋ฆฐ ์ €ํ•ญ์„ฑ ์ง€ํ‘œ์™€์˜ ์—ฐ๊ด€์„ฑ ๋ถ„์„ 10 IV. ๊ณ ์ฐฐ 11 ์ฐธ๊ณ ๋ฌธํ—Œ 16 ์˜๋ฌธ ์ดˆ๋ก 45 ๋ถ€๋ก 48Maste

    Reliability of hip migration index in children with cerebral palsy: the classic and modified methods

    Get PDF
    OBJECTIVE: To determine reliability and clinical use of two methods of migration index (MI) in CP patients with or without hip dysplasia. METHOD: The materials included radiographs of 200 hips of children with cerebral palsy. Conventional anteroposterior radiographs of the pelvis were taken with the child in the supine position with standardized methods. Two rehabilitation doctors measured the migration index using two methods. In the classic method, the lateral margin of the acetabular roof was used as a landmark and in the modified method the lateral margin of the sourcil was used as a landmark. Each rater measured the migration index at three separate times with a time interval of at least one week. Intraclass correlation (ICC) was used to test the inter- and intra-rater reliability. RESULTS: MI shows excellent intra-rater reliability in both the classic and modified methods, but the inter-rater reliability was higher in the classic method than in the modified method. When categorized according to the sourcil classification, inter-rater reliability was higher in the normal sourcil type and lower in the dysplastic sourcil types. CONCLUSION: Generally, the classic method showed higher reliability than the modified method, even though the reliability of the MI measurement was relatively high with both methods. KEYWORDS: Cerebral palsy, Hip joint, Migration index, Radiography, Reliabilityope

    The Assessment of Reliability of Cognitive Evoked Potential in Normal Person

    Get PDF
    Objective To evaluate intra-tester reliability of P300 more precisely, this study was designed. Event-related potential (ERP) is the result of endogenous brain response following cognitive stimulus. The P300 component of the human ERP is a positive wave with a latency of 300 ms or greater. Our purpose of this study was to estimate reliability of P300 latency and amplitude with 30 normal persons without head injury, as well as to set up them as the reference values in the event that they would be found to be highly reliable.Methods ERP was performed at three separate times on 30 normal adults in their 20s and 30s. We measured P300 latency and amplitude among ERP.Results P300 latency show excellent reliability with intraclass correlation coefficient (ICC) of 0.81. As to P300 amplitude, reliability was good to fair with ICC of 0.53. Average value of P300 latency was 311.3ยฑ37.0 ms, shorter than reference value of previous study in Korea.Conclusion P300 latency revealed higher reliability than P300 amplitude, although reliability of P300 was confirmed in both component. After further study including precise mechanism, influence factor on measurement and method standardization, it is expected to be an objective indicator to assess the cognitive state and predict prognosisope

    Diagnostic Value of Facial Nerve Antidromic Evoked Potential in Patients With Bellโ€™s Palsy: A Preliminary Study

    Get PDF
    OBJECTIVE: To assess the practical diagnostic value of facial nerve antidromic evoked potential (FNAEP), we compared it with the diagnostic value of the electroneurography (ENoG) test in Bell's palsy. METHODS: In total, 20 patients with unilateral Bell's palsy were recruited. Between the 1st and 17th days after the onset of facial palsy, FNAEP and ENoG tests were conducted. The degeneration ratio and FNAEP latency difference between the affected and unaffected sides were calculated in all subjects. RESULTS: In all patients, FNAEP showed prolonged latencies on the affected side versus the unaffected side. The difference was statistically significant. In contrast, there was no significant difference between sides in the normal control group. In 8 of 20 patients, ENoG revealed a degeneration ratio less than 50%, but FNAEP show a difference of more than 0.295ยฑ0.599 ms, the average value of normal control group. This shows FNAEP could be a more sensitive test for Bell's palsy diagnosis than ENoG. In particular, in 10 patients tested within 7 days after onset, an abnormal ENoG finding was noted in only four of them, but FNAEP showed a significant latency difference in all patients at this early stage. Thus, FANEP was more sensitive in detecting facial nerve injury than the ENoG test (p=0.031). CONCLUSION: FNAEP has some clinical value in the diagnosis of facial nerve degeneration. It is important that FNAEP be considered in patients with facial palsy at an early stage and integrated with other relevant tests.ope

    Aza-Claisen ์ „์œ„๋ฅผ ์ด์šฉํ•œ macrolactam์˜ ํ•ฉ์„ฑ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์•ฝํ•™๊ณผ ์•ฝํ’ˆ์ œ์กฐํ™”ํ•™์ „๊ณต,1999.Maste

    Nanohybrid photocatalyst made of titania nanosheets and zinc oxide nanoparticles via exfoliation-restacking method

    No full text
    Thesis(master`s)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :ํ™”ํ•™๋ถ€ ๋ฌผ๋ฆฌํ™”ํ•™์ „๊ณต, 2006.Maste

    EGFR T790M ๋Œ์—ฐ๋ณ€์ด๋ฅผ ์ง€๋‹Œ ๋น„์†Œ์„ธํฌํ์•”์—์„œ ๋‹น ๋Œ€์‚ฌ์˜ ์ €ํ•ด๋ฅผ ํ†ตํ•œ BIBW2992์˜ ํ•ญ์ข…์–‘ ํšจ๋Šฅ ์ฆ๋Œ€

    No full text
    Dept. of Medical Science/๋ฐ•์‚ฌThe secondary epidermal growth factor receptor (EGFR) T790M is the most common mechanism of resistance to reversible EGFR tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC) patients with activating EGFR mutations. Although BIBW2992 has been expected to overcome the resistance to reversible EGFR TKIs due to EGFR T790M mutation, it showed a limited efficacy in recent phase III clinical study. Increased glycolysis, a common feature of most cancer cells, has been considered as a potential target for treatment of cancer. In this study, it was found that the inhibition of glycolysis using 2-deoxy-D-glucose (2DG) improves the efficacy of BIBW2992 in H1975 and PC9-GR cells, the NSCLC cells with EGFR T790M. The combination treatment of 2DG and BIBW2992 induced intracellular ATP depletion in both H1975 and PC9-GR cells, resulting in activation of AMP-activated protein kinase (AMPK), the major energy-sensing kinase. The AMPK activation played a central role in the cytotoxicity by the combined treatment of 2DG and BIBW2992 through inhibition of mammalian target of rapamycin (mTOR). The alteration of AMPK/mTOR signaling pathway by the inhibition of glycolytic metabolism induced downregulation of Mcl-1, a member of anti-apoptotic Bcl-2 family which is critical for survival in H1975 and PC9-GR cells, by translational control. In in vivo xenograft study using PC9-GR cells, the combined treatment of 500 mg/kg 2DG and 5 mg/kg BIBW2992 showed more effective anti-tumor activity than the treatment of 2DG alone or BIBW2992 alone. In conclusion, this study examined whether glucose metabolism inhibition using 2DG enhances the sensitivity to BIBW2992 in NSCLC cells with EGFR T790M. Addition of 2DG increased the sensitivity to BIBW2992 accompanying apoptotic cell death in the cells. The cytotoxicity by the combination treatment of 2DG and BIBW2992 was mediated by Mcl-1 downregulation via alteration of AMPK/mTOR signaling pathway. These data suggest that the combined use of inhibitor of glycolytic metabolism and BIBW2992 is a potential therapeutic strategy for treatment of patients with acquired resistance to reversible EGFR TKIs due to secondary EGFR T790M.prohibitio

    ๊ฐ€๊ณต์ธ์‚ผ์˜ ๋Œ€์‚ฌ์‚ฐ๋ฌผ์— ๊ด€ํ•œ ์—ฐ๊ตฌ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์•ฝํ•™๊ณผ ์•ฝํ’ˆ๋ถ„์„ํ™”ํ•™์ „๊ณต,2003.Maste

    CAND1 (Cullin-associated and neddylation-dissociated protein 1) and CSN5 regulate cullin protein stability during Drosophila development

    No full text
    Thesis(masters) --์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์ƒ๋ช…๊ณผํ•™๋ถ€,2008. 8.Maste

    ์น˜๋งคํ™˜์ž๋ฅผ ์œ„ํ•œ ์น˜์œ ํ™˜๊ฒฝ์„ ๋„์ž…ํ•œ ์˜ฅ์™ธ๊ณต๊ฐ„์„ค๊ณ„์ง€์นจ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์ƒํƒœ์กฐ๊ฒฝยท์ง€์—ญ์‹œ์Šคํ…œ๊ณตํ•™๋ถ€ ์ƒํƒœ์กฐ๊ฒฝํ•™์ „๊ณต,2006.Maste
    • โ€ฆ
    corecore